Table1 Clinical data and measures of Tourette syndrome severity.
From: Associative plasticity in supplementary motor area - motor cortex pathways in Tourette syndrome
Patient | Age | Sex | Medication | DCI | PUTS | MRVS | YGTSS | YGTSS | YGTSS |
|---|---|---|---|---|---|---|---|---|---|
Motor Severity Score | Phonic Severity Score | Total Score | |||||||
P02 | 33 | m | no | 33 | 21 | 11 | 9 | 8 | 17 |
P03 | 28 | f | no | 57 | 18 | 9 | 10 | 3 | 13 |
P05 | 29 | m | Citalopram | 32 | 22 | 5 | 9 | 0 | 9 |
P06 | 45 | m | L-Thyroxin | 43 | 16 | 9 | 14 | 3 | 17 |
P07 | 20 | m | no | 49 | 20 | 8 | 14 | 0 | 14 |
P08 | 26 | m | no | 38 | 22 | 10 | 15 | 0 | 15 |
P09 | 38 | m | no | 42 | 15 | 8 | 12 | 0 | 12 |
P10 | 38 | m | no | 46 | 12 | 8 | 5 | 0 | 5 |
P11 | 26 | m | no | 34 | 15 | 9 | 9 | 7 | 16 |
P12 | 56 | m | no | n.a. | n.a. | 8 | 6 | 5 | 11 |
P13 | 29 | m | no | n.a. | 26 | 10 | 17 | 0 | 17 |
P15 | 25 | m | no | 47 | 19 | 11 | 10 | 6 | 16 |
Mean | 32.8 | 42.1 | 18.7 | 8.8 | 10.8 | 2.7 | 13.5 |
